• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病炎症中表观遗传调控功能的研究

Research on the function of epigenetic regulation in the inflammation of non-alcoholic fatty liver disease.

作者信息

Sun Lin, Yue Zhensheng, Wang Lin

机构信息

Department of Hepatobiliary Surgery, Xi-Jing Hospital, Fourth Military Medical University, Changle West Road, Xincheng District, Xi'an, Shaanxi 710032, China.

Department of Ophthalmology, Xi-Jing Hospital, Fourth Military Medical University, Changle West Road, Xincheng District, Xi'an, Shaanxi 710032, China.

出版信息

Life Med. 2024 Aug 31;3(4):lnae030. doi: 10.1093/lifemedi/lnae030. eCollection 2024 Aug.

DOI:10.1093/lifemedi/lnae030
PMID:39872862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11749620/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver condition, characterized by a spectrum that progresses from simple hepatic steatosis to nonalcoholic steatohepatitis, which may eventually lead to cirrhosis and hepatocellular carcinoma. The precise pathogenic mechanisms underlying NAFLD and its related metabolic disturbances remain elusive. Epigenetic modifications, which entail stable transcriptional changes without altering the DNA sequence, are increasingly recognized as pivotal. The principal forms of epigenetic modifications include DNA methylation, histone modifications, chromatin remodeling, and noncoding RNAs. These alterations participate in the regulation of hepatic lipid metabolism, insulin resistance, mitochondrial injury, oxidative stress response, and release of inflammatory cytokines, all of which are associated with the onset and progression of NAFLD. This review discussed recent advances in understanding the potential epigenetic regulation of inflammation in NAFLD. Unraveling these epigenetic mechanisms may facilitate the identification of early diagnostic biomarkers and the development of targeted therapeutic strategies for NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD)是最常见的慢性肝脏疾病,其特征是一个从单纯性肝脂肪变性发展到非酒精性脂肪性肝炎的谱系,最终可能导致肝硬化和肝细胞癌。NAFLD及其相关代谢紊乱的精确致病机制仍不清楚。表观遗传修饰,即导致稳定的转录变化而不改变DNA序列,越来越被认为是关键因素。表观遗传修饰的主要形式包括DNA甲基化、组蛋白修饰、染色质重塑和非编码RNA。这些改变参与肝脏脂质代谢、胰岛素抵抗、线粒体损伤、氧化应激反应和炎性细胞因子释放的调节,所有这些都与NAFLD的发生和发展有关。本文综述了在理解NAFLD炎症潜在表观遗传调控方面的最新进展。阐明这些表观遗传机制可能有助于识别早期诊断生物标志物,并为NAFLD开发靶向治疗策略。

相似文献

1
Research on the function of epigenetic regulation in the inflammation of non-alcoholic fatty liver disease.非酒精性脂肪性肝病炎症中表观遗传调控功能的研究
Life Med. 2024 Aug 31;3(4):lnae030. doi: 10.1093/lifemedi/lnae030. eCollection 2024 Aug.
2
Potential epigenetic mechanism in non-alcoholic Fatty liver disease.非酒精性脂肪性肝病中的潜在表观遗传机制。
Int J Mol Sci. 2015 Mar 5;16(3):5161-79. doi: 10.3390/ijms16035161.
3
Epigenetics in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中的表观遗传学。
Mol Aspects Med. 2017 Apr;54:78-88. doi: 10.1016/j.mam.2016.11.008. Epub 2016 Nov 23.
4
Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease.瘦型非酒精性脂肪性肝病中的表观遗传调控。
Int J Mol Sci. 2023 Aug 16;24(16):12864. doi: 10.3390/ijms241612864.
5
Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD).氧化还原平衡和非酒精性脂肪性肝病 (NAFLD) 的表观遗传学。
Curr Pharm Des. 2013;19(15):2737-46. doi: 10.2174/1381612811319150009.
6
Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH).非酒精性脂肪性肝病(NAFLD)/非酒精性脂肪性肝炎(NASH)的分子机制。
Adv Exp Med Biol. 2021;1261:223-229. doi: 10.1007/978-981-15-7360-6_20.
7
Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review.解析表观遗传修饰在脂肪性肝病中的作用:系统评价。
Eur J Clin Invest. 2021 May;51(5):e13479. doi: 10.1111/eci.13479. Epub 2021 Jan 4.
8
Histone Modifications in NAFLD: Mechanisms and Potential Therapy.非酒精性脂肪性肝病中组蛋白修饰:机制与潜在治疗策略。
Int J Mol Sci. 2023 Sep 27;24(19):14653. doi: 10.3390/ijms241914653.
9
MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease.微小 RNA 在非酒精性脂肪性肝病发病机制中的作用。
Int J Biol Sci. 2021 Apr 29;17(7):1851-1863. doi: 10.7150/ijbs.59588. eCollection 2021.
10
Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition.非酒精性脂肪性肝病与营养之间联系的表观遗传机制
Nutrients. 2014 Aug 21;6(8):3303-25. doi: 10.3390/nu6083303.

引用本文的文献

1
Research on biliary atresia and epigenetic factors from the perspective of transcriptomics: identification of key genes and experimental validation.从转录组学角度对胆道闭锁和表观遗传因素的研究:关键基因的鉴定与实验验证
Front Pediatr. 2025 Jul 17;13:1624671. doi: 10.3389/fped.2025.1624671. eCollection 2025.
2
Gene therapy strategies for aging intervention.衰老干预的基因治疗策略。
Cell Insight. 2025 May 23;4(4):100254. doi: 10.1016/j.cellin.2025.100254. eCollection 2025 Aug.

本文引用的文献

1
Histone demethylase KDM1A promotes hepatic steatosis and inflammation by increasing chromatin accessibility in NAFLD.组蛋白去甲基化酶 KDM1A 通过增加 NAFLD 中的染色质可及性促进肝脂肪变性和炎症。
J Lipid Res. 2024 Mar;65(3):100513. doi: 10.1016/j.jlr.2024.100513. Epub 2024 Jan 29.
2
Histone Modifications in NAFLD: Mechanisms and Potential Therapy.非酒精性脂肪性肝病中组蛋白修饰:机制与潜在治疗策略。
Int J Mol Sci. 2023 Sep 27;24(19):14653. doi: 10.3390/ijms241914653.
3
A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression.
表观遗传修饰与非酒精性脂肪性肝病进展的串扰。
Pathol Res Pract. 2023 Nov;251:154809. doi: 10.1016/j.prp.2023.154809. Epub 2023 Sep 16.
4
Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study.代谢性疾病中的表观遗传调控:机制及临床研究进展。
Signal Transduct Target Ther. 2023 Mar 2;8(1):98. doi: 10.1038/s41392-023-01333-7.
5
LncRNA ZFAS1 ameliorates injury led by non-alcoholic fatty liver disease via suppressing lipid peroxidation and inflammation.长链非编码RNA ZFAS1通过抑制脂质过氧化和炎症反应减轻非酒精性脂肪性肝病所致损伤。
Clin Res Hepatol Gastroenterol. 2023 Jan;47(1):102067. doi: 10.1016/j.clinre.2022.102067. Epub 2022 Dec 10.
6
Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications.探讨环状 RNA 在非酒精性脂肪性肝病及其并发症发病机制中的作用。
Front Endocrinol (Lausanne). 2022 Nov 2;13:1035159. doi: 10.3389/fendo.2022.1035159. eCollection 2022.
7
Disease State Transition Probabilities Across the Spectrum of NAFLD: A Systematic Review and Meta-Analysis of Paired Biopsy or Imaging Studies.非酒精性脂肪性肝病(NAFLD)各阶段疾病状态转变概率:配对肝活检或影像学研究的系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2023 May;21(5):1154-1168. doi: 10.1016/j.cgh.2022.07.033. Epub 2022 Aug 4.
8
RPA1 controls chromatin architecture and maintains lipid metabolic homeostasis.RPA1 控制染色质结构并维持脂质代谢平衡。
Cell Rep. 2022 Jul 12;40(2):111071. doi: 10.1016/j.celrep.2022.111071.
9
MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH.miR-690 治疗可减少 NASH 中的纤维化和脂肪变性,并恢复特定的库普弗细胞功能。
Cell Metab. 2022 Jul 5;34(7):978-990.e4. doi: 10.1016/j.cmet.2022.05.008. Epub 2022 Jun 13.
10
Lipid metabolism dysfunction induced by age-dependent DNA methylation accelerates aging.年龄相关的 DNA 甲基化导致的脂质代谢功能障碍加速衰老。
Signal Transduct Target Ther. 2022 May 25;7(1):162. doi: 10.1038/s41392-022-00964-6.